Bladder Cancer

The only top 10 cancer where survival rates are falling

Of the top 10 cancers in the UK, bladder cancer is only one where survival rates have been shown to be getting worse. New figures published this month in the Journal of Clinical Urology confirm in a study of cases of bla ...

Feb 25, 2014
popularity 4.5 / 5 (35) | comments 0

COXEN model picks the best drug for ovarian cancer

There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug ...

Feb 18, 2014
popularity 5 / 5 (1) | comments 0

Cancer patients diagnosed more quickly

(Medical Xpress)—The time taken to diagnose some of the more common cancers – from the point when a patient first reports a possible symptom to their general practitioner (GP) – fell in adults by an average of five ...

Feb 05, 2014
popularity 4 / 5 (1) | comments 0

Bladder cancer is any of several types of malignancy arising from the epithelial lining (i.e. "the urothelium") of the urinary bladder. The bladder is rarely involved by non-epithelial cancers (such as lymphoma or sarcoma) but these are not properly included in the colloquial term "bladder cancer." It is a disease in which abnormal cells multiply without control in the bladder. The bladder is a hollow, muscular organ that stores urine; it is located in the pelvis. The most common type of bladder cancer recapitulates the normal histology of the urothelium and is known as transitional cell carcinoma.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Turning off depression in the brain

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Building 'smart' cell-based therapies

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...